[go: up one dir, main page]

NL7803418A - 15-deoxy-16-hydroxy-16-gesubstitueerde prostaan- zuren, werkwijzen ter bereiding daarvan alsmede farmaceutische preparaten, die deze verbindin- gen als actieve component bevatten. - Google Patents

15-deoxy-16-hydroxy-16-gesubstitueerde prostaan- zuren, werkwijzen ter bereiding daarvan alsmede farmaceutische preparaten, die deze verbindin- gen als actieve component bevatten.

Info

Publication number
NL7803418A
NL7803418A NL7803418A NL7803418A NL7803418A NL 7803418 A NL7803418 A NL 7803418A NL 7803418 A NL7803418 A NL 7803418A NL 7803418 A NL7803418 A NL 7803418A NL 7803418 A NL7803418 A NL 7803418A
Authority
NL
Netherlands
Prior art keywords
substituated
prostane
deoxy
hydroxy
acids
Prior art date
Application number
NL7803418A
Other languages
English (en)
Dutch (nl)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/782,858 external-priority patent/US4131737A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NL7803418A publication Critical patent/NL7803418A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C07C45/305—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/02—Lithium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896—Compounds having one or more Si-O-acyl linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL7803418A 1977-03-30 1978-03-30 15-deoxy-16-hydroxy-16-gesubstitueerde prostaan- zuren, werkwijzen ter bereiding daarvan alsmede farmaceutische preparaten, die deze verbindin- gen als actieve component bevatten. NL7803418A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/782,858 US4131737A (en) 1976-07-19 1977-03-30 15-Deoxy-16-hydroxy-16-substituted-3-thia-prostanoic acids

Publications (1)

Publication Number Publication Date
NL7803418A true NL7803418A (nl) 1978-10-03

Family

ID=25127398

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7803418A NL7803418A (nl) 1977-03-30 1978-03-30 15-deoxy-16-hydroxy-16-gesubstitueerde prostaan- zuren, werkwijzen ter bereiding daarvan alsmede farmaceutische preparaten, die deze verbindin- gen als actieve component bevatten.

Country Status (9)

Country Link
JP (1) JPS5439047A (fr)
AU (1) AU3437478A (fr)
BE (1) BE865428R (fr)
DE (1) DE2813342A1 (fr)
DK (1) DK137778A (fr)
ES (2) ES468353A1 (fr)
FR (1) FR2385696A2 (fr)
NL (1) NL7803418A (fr)
SE (1) SE7803619L (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU529836B2 (en) * 1977-12-05 1983-06-23 American Cyanamid Company Prostaglandin analog
JPH0424232Y2 (fr) * 1987-09-14 1992-06-08
FR2621376B1 (fr) * 1987-10-01 1989-12-22 Pont A Mousson Garniture d'etancheite pour joints verrouilles telescopiques
FR2655705B1 (fr) * 1989-12-11 1992-05-29 Pont A Mousson Garniture d'etancheite composite pour assemblage verrouille de tuyaux a bout male et emboitement.
CA2147461A1 (fr) * 1992-10-21 1994-04-28 Takehiro Amano Analogues de la prostaglandine e1
US5618959A (en) * 1995-03-10 1997-04-08 Vivus Incorporated Process for preparing prostaglandin E1, E2 and analogs thereof using furylcopper reagents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965143A (en) * 1974-03-26 1976-06-22 G. D. Searle & Co. 16-Oxygenated prostanoic acid derivatives
AU529836B2 (en) * 1977-12-05 1983-06-23 American Cyanamid Company Prostaglandin analog

Also Published As

Publication number Publication date
BE865428R (fr) 1978-09-29
JPS5439047A (en) 1979-03-24
SE7803619L (sv) 1978-11-17
ES468353A1 (es) 1979-10-01
AU3437478A (en) 1979-09-27
ES481198A1 (es) 1980-09-01
DK137778A (da) 1978-10-01
FR2385696A2 (fr) 1978-10-27
DE2813342A1 (de) 1978-10-05

Similar Documents

Publication Publication Date Title
NL7802792A (nl) Cefem- en cefam-verbindingen met antimicrobiele werking, werkwijzen ter bereiding daarvan, als- mede farmaceutische preparaten die deze verbin- dingen als actieve component bevatten.
NL7803195A (nl) Heterocyclische verbindingen met farmaceutische activiteit, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten, die deze verbindingen als actieve component bevatten.
NL7714329A (nl) Werkwijze ter bereiding van 3-de-0-methylforti- micinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL8103768A (nl) Heterocyclische verbindingen, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7707750A (nl) Werkwijze ter bereiding van gesulfateerde oligo- sacchariden, alsmede farmaceutische preparaten die deze verbindingen als actieve component be- vatten.
NL7708741A (nl) Werkwijze ter bereiding van prostaanzuurderiva- ten alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten.
NL7700379A (nl) Werkwijze ter bereiding van anthracyclinegly- cosiden, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7702548A (nl) Werkwijze ter bereiding van 3,7-digesubstitueerde- -3-cefem-4-carbonzuurverbindingen, alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten.
NL7603193A (nl) Werkwijze ter bereiding van acyclische, alicycli- sche en aromatische n-gesubstitueerde halogeen-2- -pyrrolidinonen met herbicidewerking alsmede her- bicidepreparaten die deze verbindingen als actie- ve component bevatten.
NL7804345A (nl) Imidazoazinen en imidazodiazinen, werkwijze ter berei- ding daarvan en farmaceutische preparaten.
NL7808475A (nl) Anthrachinonverbindingen, werkwijzen ter bereiding daarvan alsmede samenstellingen en preparaten die deze verbindingen als actieve component bevatten.
NL7706064A (nl) Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten.
NL184467C (nl) 6-oxo-prostaglandine eŸ1 derivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten, die deze bevatten.
NL7705141A (nl) Werkwijze ter bereiding van prostaglandine deri- vaten, alsmede farmaceutische preparaten die deze verbinding als actieve component bevatten.
NL7607337A (nl) Werkwijze ter bereiding van spirocycloalkyl- prostaanzuren en derivaten daarvan, alsmede geneeskundige preparaten die deze verbindingen als actieve component bevatten.
NL7708982A (nl) Werkwijze ter bereiding van dihydro-oxo-nicotine- zuren, alsmede farmaceutische preparaten die de- ze verbinding als actieve component bevatten.
NL187397C (nl) Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding.
NL7711414A (nl) Werkwijze ter bereiding van n-gesubstitueerde lactamen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7702180A (nl) Werkwijze ter bereiding van 9-gesubstitueerde- -8-azapurinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7803418A (nl) 15-deoxy-16-hydroxy-16-gesubstitueerde prostaan- zuren, werkwijzen ter bereiding daarvan alsmede farmaceutische preparaten, die deze verbindin- gen als actieve component bevatten.
NL7707150A (nl) Werkwijze ter bereiding van 2-lagere alkyl-7-ge- substitueerde-2 of 3-cefem-4-carbonzuurverbin- dingen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7714063A (nl) Werkwijze ter bereiding van imidazolinen alsmede pesticidepreparaten die deze verbindingen als actieve component bevatten.
NL7613334A (nl) Werkwijze ter bereiding van carbamaat-sulfenyl- -carbamoylfluorideverbindingen, alsmede pestici- de preparaten die deze verbindingen als actieve component omvatten.
NL7810758A (nl) Gesubstitueerde 7 beta-amidino-delta3-cefem-4-carbon- zuren alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7708377A (nl) Werkwijze ter bereiding van farmacologisch ac- tieve verbindingen alsmede preparaten die deze verbindingen als actieve component omvatten.

Legal Events

Date Code Title Description
BV The patent application has lapsed